|
Report No. : |
316162 |
|
Report Date : |
06.04.2015 |
IDENTIFICATION DETAILS
|
Name : |
SALUTAS PHARMA GMBH |
|
|
|
|
Registered Office : |
Otto-von-Guericke-Allee 1, D 39179
Barleben |
|
|
|
|
Country : |
Germany |
|
|
|
|
Date of Incorporation : |
21.12.1990 |
|
|
|
|
Legal Form : |
Private Limited Company |
|
|
|
|
Line of Business : |
·
Manufacture
of pharmaceutical preparations ·
Wholesale of
pharmaceutical, medical and orthpedic goods |
|
|
|
|
No. of Employees : |
1,400 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – December 31, 2014
|
Country Name |
Previous Rating (30.09.2014) |
Current Rating (31.12.2014) |
|
Germany |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
GERMANY - ECONOMIC OVERVIEW
The German economy - the
fifth largest economy in the world in PPP terms and Europe's largest - is a
leading exporter of machinery, vehicles, chemicals, and household equipment and
benefits from a highly skilled labor force. Like its Western European
neighbors, Germany faces significant demographic challenges to sustained
long-term growth. Low fertility rates and declining net immigration are
increasing pressure on the country's social welfare system and necessitate
structural reforms. Reforms launched by the government of Chancellor Gerhard
SCHROEDER (1998-2005), deemed necessary to address chronically high
unemployment and low average growth, has contributed to strong growth and falling
unemployment. These advances, as well as a government subsidized, reduced
working hour scheme, help explain the relatively modest increase in
unemployment during the 2008-09 recession - the deepest since World War II -
and its decrease to 5.3% in 2013. The new German government introduced a
minimum wage of $11 per hour to take effect in 2015. Stimulus and stabilization
efforts initiated in 2008 and 2009 and tax cuts introduced in Chancellor Angela
MERKEL's second term increased Germany's total budget deficit - including
federal, state, and municipal - to 4.1% in 2010, but slower spending and higher
tax revenues reduced the deficit to 0.8% in 2011 and in 2012 Germany reached a
budget surplus of 0.1%. A constitutional amendment approved in 2009 limits the
federal government to structural deficits of no more than 0.35% of GDP per
annum as of 2016 though the target was already reached in 2012. Following the
March 2011 Fukushima nuclear disaster, Chancellor Angela MERKEL announced in
May 2011 that eight of the country's 17 nuclear reactors would be shut down
immediately and the remaining plants would close by 2022. Germany hopes to
replace nuclear power with renewable energy. Before the shutdown of the eight
reactors, Germany relied on nuclear power for 23% of its electricity generating
capacity and 46% of its base-load electricity production.
|
Source
: CIA |
SALUTAS PHARMA GMBH
Company Status: active
Otto-von-Guericke-Allee 1
D 39179 Barleben
Telephone:039203/710
Telefax:
039203/717770
Homepage: www.salutas.de
E-mail:
info.salutas@sandoz.com
VAT
no.: DE139235165
Business relations are permissible.
LEGAL FORM Private limited company
Date of foundation: 21.12.1990
Shareholders'
agreement: 21.12.1990
Registered on: 13.08.1993
Commercial
Register: Local court 39576 Stendal
under: HRB 105793
Share capital: EUR 42,100,000.00
Shareholder:
H e x a l
Aktiengesellschaft
Industriestr. 25
D 83607 Holzkirchen
Legal form: Public
limited company
Share capital: EUR
93,694,237.23
Share: EUR 42,100,000.00
Registered on: 03.08.1995
Reg. data: 80333 München,
HRB 110375
Control and profit
transfer agreement
Manager:
Norbert Marquardt
Ahrensfelder Weg 9
D 22927 Großhansdorf
born: 24.05.1958
Manager:
Burkart Gert Broede
D 20095 Hamburg
born: 01.10.1974
Manager:
Jeffrey Simon Francis
D 65033 Wiesbaden
born: 11.12.1971
Proxy:
Gerhard Bauer
D 38350 Helmstedt
authorized to jointly
represent the company
born: 24.05.1961
Proxy:
Sabine Austermann
D 38100 Braunschweig
authorized to jointly
represent the company
Proxy:
Gert Magnus Baron von
Stackelberg
D 10115 Berlin
authorized to jointly
represent the company
born: 29.04.1950
Proxy:
Norman Scheider
Salvador-Allende-Str. 2
D 39126 Magdeburg
authorized to jointly represent the company
born: 09.12.1970
Proxy:
Cathleen Filor
D 39291 Möser
authorized to jointly
represent the company
Proxy:
Dr. Irmgard Neuper
D 71229 Leonberg
authorized to jointly
represent the company
born: 04.03.1970
Proxy:
Fred Wulfgramm
Schneppruthe 18
D 51469 Bergisch Gladbach
authorized to jointly
represent the company
born: 10.09.1962
Proxy:
Lutz Rüdiger Springer
D 22962 Siek
authorized to jointly represent the company
born: 29.08.1963
Proxy:
Notker Walter Karpf
D 55437 Ockenheim
authorized to jointly
represent the company
born: 12.02.1963
Proxy:
Jörg Ullrich Schöfthaler
D 90562 Heroldsberg
authorized to jointly
represent the company
born: 21.01.1966
02.09.2011 - 26.06.2014 Manager
Thomas Alexander Baur
D 35037 Marburg
Main industrial sector
21200
Manufacture of pharmaceutical preparations
4646
Wholesale of pharmaceutical, medical and orthpedic goods
Works:
Salutas Pharma GmbH
Lange Göhren 3
D 39171 Sülzetal
TEL.: 039205/421000
FAX.: 039205/421240
Branch:
Salutas Pharma GmbH
Dieselstr. 5
D 70839 Gerlingen
Payment experience: within agreed terms
Negative information:We have no negative information
at hand.
Type of ownership: Beneficiary
Address Otto-von-Guericke-Allee 1
D 39179 Barleben
Type of real estate: factory building
Type of ownership: Tenant
Address Lange Göhren 3
D 39171 Sülzetal
Land register documents were not available.
Principal bank
COMMERZBANK VORMALS DRESDNER BANK, 39003
MAGDEBURG
Sort. code: 81080000
BIC: DRESDEFF810
Further banks
DEUTSCHE BANK, 39001 MAGDEBURG
Sort. code: 81070000
BIC: DEUTDE8MXXX
UNICREDIT BANK - HYPOVEREINSBANK, 80311
MÜNCHEN
Sort. code: 70020270
BIC: HYVEDEMMXXX
Financial year: 01.01. - 31.12.
Turnover: 2013 EUR 900,000,000.00
2014 EUR 900,100,000.00
further business figures:
Share capital: EUR 42,100,000.00
Equipment: *EUR 8,208,000.00
Ac/ts receivable: *EUR 9,576,000.00
Liabilities: *EUR 23,940,000.00
Employees:
1,400
-
Trainees:
32
Control and profit transfer agreement to:
H e x a l
Aktiengesellschaft
Industriestr. 25
D 83607 Holzkirchen
The
business figures marked with an asterisk are estimates based on average values
in the line of business.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.62.59 |
|
|
1 |
Rs.92.46 |
|
Euro |
1 |
Rs.67.51 |
INFORMATION DETAILS
|
Analysis Done by
: |
DIV |
|
|
|
|
Report Prepared
by : |
ASH |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
|
41-55 |
Ba |
Overall
operation is considered normal. Capable to meet normal commitments. |
Satisfactory |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
|
-- |
NB |
New Business |
-- |
|
This score serves as a reference to assess SC’s
credit risk and to set the amount of credit to be extended. It is calculated
from a composite of weighted scores obtained from each of the major sections of
this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or
its officials.